AMYGDALA vs BrainQ
AMYGDALA vs BrainQ, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AMYGDALA is on 31/100 and BrainQ on 56/100.
Where each one leads
AMYGDALA
- agent readiness: 50/100 against 40/100
BrainQ
- our overall score: 56/100 against 31/100
- domain rating: 36/100 against 1/100
- headcount: 29 against 9
- LinkedIn following: 8,150 against 9
At a glance
| Measure | AMYGDALA | BrainQ |
|---|---|---|
| What it is | Developing AI-driven technology for mental health treatments, focusing on PTSD. | Bioelectric medicine company advancing neurorecovery for stroke and neurological conditions. |
| Category | Healthcare, PTSD, Mental Health, Personalized | Healthcare, Neurology, Mental Health, Strokes |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software, Hardware |
| Founded | 2017 | 2011 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | AMYGDALA | BrainQ |
|---|---|---|
| Employees | 9 | 29 |
| Headcount growthLast 12 months | +74.8% | Not published |
| Total funding | Not published | $45.3M |
| Latest round | Not published | Series B |
| LinkedIn followers | 9 | 8,150 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AMYGDALA | BrainQ |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 31/100 | 56/100 |
| Traction | 10/100 | 53/100 |
| Team | 60/100 | 70/100 |
| Search visibility | 15/100 | 31/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 1/100 | 36/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AMYGDALA | BrainQ |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Webflow |
| Frameworks | Not detected | Bootstrap |
| Analytics | Not detected | Google Tag Manager |
What users say
| Measure | AMYGDALA | BrainQ |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 4 positive, 0 negative across 4 threads |
“Daily Crunch: Israel-based stroke therapy tech startup BrainQ raises $40M.”r/techcrunch
AMYGDALA vs BrainQ: common questions
Which is better, AMYGDALA or BrainQ?
On our 0-100 score BrainQ rates higher (56/100 against 31/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do AMYGDALA and BrainQ compare on the numbers?
AMYGDALA leads on agent readiness (50/100 against 40/100). BrainQ leads on our overall score (56/100 against 31/100), domain rating (36/100 against 1/100), headcount (29 against 9), LinkedIn following (8,150 against 9).
What do real users say about AMYGDALA and BrainQ?
BrainQ: 4 positive and 0 negative mentions across 4 Reddit threads we track, mostly in r/techcrunch.
Read the full AMYGDALA review and pricing or the BrainQ review and pricing. You can also browse other AMYGDALA alternatives we track.